http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3137128-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27f1d33ed510f63c702c19904e4ee5d7 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
filingDate | 2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e6171782626710a2e278e81fffe00d2 |
publicationDate | 2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-3137128-A1 |
titleOfInvention | Genetic risk analysis for attention deficit/hyperactivity disorders and behavioral management thereof |
abstract | Methods and kits for assessing severity index for genetic risks of attention deficit/hyperactivity disorders. The present invention further relates to methods for behavioral management thereof. The methods and kits provide a risk analysis score (termed a "genetic risk attention deficit disorder score" (or "GRADDS"). The method for behavioral management of those depending upon his or her GRADDS is the precision behavioral management (or PBM") protocol. This can include precision addiction management and pro-dopamine lifestyle therapies and measures. |
priorityDate | 2019-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 575.